These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14070550)

  • 21. [APROPOS OF THE REPORT: ACETYLZOXAZOLAMINE IN THE TREATMENT OF GOUT: INITIAL RESULTS].
    SERRE H; SIMON L; CLAUSTRE J
    Rev Rhum Mal Osteoartic; 1963 Jun; 30():371-2. PubMed ID: 14070100
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the determination of uricosuric activity in the rat].
    Coppi G; Bonardi G
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):712-3. PubMed ID: 5876561
    [No Abstract]   [Full Text] [Related]  

  • 23. [Increase in blood uric acid during treatment with chlorothiazide].
    OSTERGAARD KRISTENSEN HP; MOSBECH J
    Ugeskr Laeger; 1960 Mar; 122():284-6. PubMed ID: 14429293
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chlorothiazide and uric acid elimination].
    Vorburger C; Reubi F
    Helv Med Acta; 1963 Nov; 30(4):593-602. PubMed ID: 5878829
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of phenylbutazone on uric acid in plasma and erythrocytes; relation to clinical phenomena].
    LEVY M; SICHERE RM
    Rev Rhum Mal Osteoartic; 1955 Mar; 22(3):225-33. PubMed ID: 14396123
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recent results obtained with anti-inflammatory and uricosuric therapeutics in certain peripheral angiopathies. Clinical trials of ketophenylbutazone].
    Bourde C
    Therapie; 1966; 21(4):1053-61. PubMed ID: 5925076
    [No Abstract]   [Full Text] [Related]  

  • 27. [URICO-ELIMINATOR TREATMENT OF CHRONIC GOUT].
    BENE P
    Fr Med; 1963 May; 26():304-5. PubMed ID: 14060963
    [No Abstract]   [Full Text] [Related]  

  • 28. [The action of chlorothiazide on the elimination of uric acid].
    LINDEBOOM GA
    Minerva Med; 1961 Jun; 52():2262-3. PubMed ID: 13762289
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ketophenylbutazone, its metabolism and its effect on the uric acid content in the blood and urine].
    SIBLIKOVA O; LAVICKA J; VACHEK G; TESAREK B; VITULOVA O; CERNA M
    Arzneimittelforschung; 1961 Dec; 11():1106-8. PubMed ID: 13912488
    [No Abstract]   [Full Text] [Related]  

  • 30. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. INFLAMMATORY POLYARTHRITIC DISEASE. IV. GOUT.
    MASON RM
    J Coll Gen Pract; 1963 Aug; 6(Suppl 3):SUPPL 3:50-3. PubMed ID: 14060430
    [No Abstract]   [Full Text] [Related]  

  • 32. [The pleiotropic effects of losartan--the importance of decreasing uric acid level].
    Csiky B; Markó L; Mohás M; Cseh J; Mikolás E; Szíjártó I; Wittmann I
    Lege Artis Med; 2008 Oct; 18(10):663-6. PubMed ID: 19227608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials of uric acid lowering for coronary heart disease risk reduction.
    Simon JA
    Am J Med; 2006 Apr; 119(4):e5; author reply e7. PubMed ID: 16564763
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparison of the hyperuricaemic effect of chlorothiazide and quinethazone.
    Mathew TH; Kincaid-Smith P; Doyle AE; Baird CW
    Med J Aust; 1967 Mar; 1(10):493-5. PubMed ID: 6022910
    [No Abstract]   [Full Text] [Related]  

  • 35. [Uric acid metabolism and the liver; behavior of the uricemia overload curve in liver patients during lipotropic therapy].
    ANGLESIO D; GALLI E
    Arch Sci Med (Torino); 1951 Jan; 91(1):66-104. PubMed ID: 14820575
    [No Abstract]   [Full Text] [Related]  

  • 36. Case 8: initiation of urate-lowering therapy for standard advanced gout.
    Finley JM
    Am J Med; 2006 Nov; 119(11 Suppl 1):S25-8. PubMed ID: 17059910
    [No Abstract]   [Full Text] [Related]  

  • 37. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML
    N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract]   [Full Text] [Related]  

  • 38. [Badly managed gout for decades. Only then do the hands look this way].
    Füessl HS
    MMW Fortschr Med; 2006 May; 148(18):23. PubMed ID: 16736681
    [No Abstract]   [Full Text] [Related]  

  • 39. Antihyperuricemic lignans from the leaves of Phyllanthus niruri.
    Murugaiyah V; Chan KL
    Planta Med; 2006 Nov; 72(14):1262-7. PubMed ID: 16953466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid.
    George J; Carr E; Davies J; Belch JJ; Struthers A
    Circulation; 2006 Dec; 114(23):2508-16. PubMed ID: 17130343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.